AstroCOMET · Astrocyte-neuron COmmunication in METabolism and obesity.
Horizon 2020 — Marie Skłodowska-Curie Actions
- Duration
- 2020-04-01 → 2022-03-31
- EU contribution
- €174,806
- Participants
- 1
- Scheme
- MSCA-IF-EF-ST
Lines connect the coordinator with its partners.
Results in brief
Astrocyte-neuron COmmunication in METabolism and obesity.
Obesity and its associated comorbidities, such as type 2 diabetes, have become highly prevalent in our society and represent two major health threats for the future. Recent epidemiological data from the WHO showed that more than 1.9 billion adults aged 18 years and older are overweight and over 650 million adults are obese. Overall, about 13% of the world’s adult population (11% of men and 15% of women) is obese. The situation has reached epidemic proportions globally, with at least 2.8 million people dying each year as a result of being overweight or obese. This medical problem is the consequence of an energy imbalance between calories consumed and calories expended, but the fundamental pathophysiological causes leading to this imbalance are still not properly understood. In addition, despite decades of research, the development of safe and effective anti-obesity treatments has not been successful enough to correct the increasing presence of both maladies. The current state of the art, have identified the brain as the main regulator of systemic metabolism, suggesting that obesity has a brain-centered context. In particular, the hypothalamus acts as a center of the metabolic homeostasis by integrating constant inputs from circulating nutrients and endocrine signals and generating the appropriate physiological responses to maintain a balanced systemic metabolism and a stable body weight. While decades of investigations have resulted in major insights into how hypothalamic neurons govern feeding behavior and systemic metabolism, recent work suggests that the current model is constrained by the assumption that neurons are the only brain cell types involved in the central control of energy homeostasis. In particular, astrocytes, have recently been shown to be involved in the functional regulation of metabolism. For instance, high fat diet (HFD) induces metabolic and morphological disturbances in the hypothalamus including changes in its cytoarchitecture affecting how astrocytes interact physically with pro-opiomelanocortin (POMC) and neuropeptide Y (NPY) neurons in the hypothalamus – essential neuronal populations for the maintenance of energy homeostasis. Moreover, it has recently been reported that insulin receptors (IRs) in astrocytes were important players for the regulation of glucose homeostasis. Overall, together these results suggest a new paradigm in which astrocytes interplay with neurons for the CNS control of metabolism, body weight, and energy balance. However, the mechanisms by which astrocytes communicate with neurons to adjust the activity of feeding circuits and systemic metabolism in response to whole body energy demands remains to be investigated. Therefore, the overall objective of the AstroCOMET project was to study the role of hypothalamic astrocytes in the control of metabolism and how alterations in their function could be part of the obesity pathophysiology.
Data: CORDIS, © European Union
Project objective
Obesity and type 2 diabetes have been increasing during the last decades, becoming highly prevalent diseases in our society. Until very recently, astrocytes and other glial cells have been traditionally known as supportive cells to neurons, but the host research group led by Prof. Matthias Tschöp has recently reported that insulin receptors (IRs) in astrocytes regulate glucose delivery into the brain and lack thereof leads to a reduced response of glucose-induced suppression of food intake (Garcia-Caceres et al., Cell 2016). These data, together with previous findings, suggest a new paradigm in which astrocytes interplay with neurons in the CNS control of metabolism, body weight, and energy balance. However, the molecular underpinnings remain to be investigated. My main objective is to test the hypothesis that astrocyte-neuron communication is required for maintaining a normal energy homeostasis, and its impairment contributes to the pathogenesis of obesity. To achieve this, I will use Designer Receptors Exclusively Activated by Designer Drugs (DREADD) technology to examine whether astrocyte activity is required for maintaining a normal energy homeostasis. I will generate two transgenic mouse models (dnSNARE mouse and iBot mouse) to specifically interfere with the release of gliotransmitters in order to test whether astrocytes release vesicles to regulate the activity of hypothalamic neurons in the control of energy metabolism. Finally, I will investigate whether hypercaloric diet disrupts astrocyte-neuron communication, thus contributing to obesity progression. This project has the potential to reveal new mechanism(s) of metabolic homeostasis and how its impairment explains the development of obesity. Moreover, this proposal will enhance my individual competence in terms of skill acquisition and creativity through an advanced training in a privileged host environment; representing all together a significant contribution to the Horizon 2020 Work Programme.
Original text from CORDIS.
Participants
- HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH · NeuherbergCoordinatorGermany
Links
Data: CORDIS, © European Union
